Key Events This Week
7 Sep: Intraday high of Rs.424.80 amid 8.15% surge
9 Sep: Technical momentum shifts to bullish trend
11 Sep: New 52-week and all-time high at Rs.466.85
11 Sep: Intraday surge of 8.97% to Rs.466
11 Sep: Week closes at Rs.464.30 (+18.23%)

Broad-Based Technical Strength Lifts SMS Pharmaceuticals Ltd to 52-Week High of Rs 466.85
2026-09-11 10:36:56Surging to a fresh 52-week and all-time high of Rs 466.85 on 11 Sep 2026, SMS Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex backdrop.
Read full news article
SMS Pharmaceuticals Ltd Surges 8.97% to Day's High of Rs 466 — Outperforms Sector by 11.84 Percentage Points
2026-09-11 10:17:04The Sensex declined 0.69% on 11 Sep 2026, while SMS Pharmaceuticals Ltd surged 8.97%, reaching an intraday high of Rs 466. This 11.84-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
SMS Pharmaceuticals Ltd is Rated Sell
2026-09-11 10:11:08SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Strong Momentum Meets Stretched Valuations as SMS Pharmaceuticals Ltd Reaches All-Time High
2026-09-11 10:05:28Extending its winning streak to eight sessions, SMS Pharmaceuticals Ltd surged 8.72% on 11 Sep 2026 to touch an intraday high of Rs 444.5, closing near its 52-week peak of Rs 446.5. This rally has propelled the stock to a fresh all-time high, outpacing the Sensex which declined 0.79% on the same day.
Read full news article
SMS Pharmaceuticals Ltd Technical Momentum Shifts Amid Bullish Signals
2026-09-09 08:02:32SMS Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite this positive directional change, the stock’s technical indicators present a nuanced picture, with some signals suggesting caution. This article analyses the recent technical parameter changes, key momentum indicators, and the implications for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
SMS Pharmaceuticals Ltd Surges 8.15% to Day's High of Rs 424.8 — Outperforms Sector by 7.8 Percentage Points
2026-09-07 10:21:40The Sensex declined 0.43% on 07 Sep 2026, while SMS Pharmaceuticals Ltd surged 8.15%, touching an intraday high of Rs 424.8. This 7.8-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
SMS Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Risk Amid Strong Returns
2026-09-07 08:00:20SMS Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from expensive to very expensive territory, despite delivering robust stock returns well above the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid the company’s evolving market position.
Read full news article
SMS Pharmaceuticals Ltd is Rated Sell
2026-08-31 10:10:21SMS Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article





